A detailed history of Auxano Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Auxano Advisors, LLC holds 6,286 shares of ABT stock, worth $745,519. This represents 0.19% of its overall portfolio holdings.

Number of Shares
6,286
Previous 1,787 251.76%
Holding current value
$745,519
Previous $203,000 221.67%
% of portfolio
0.19%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$100.73 - $112.44 $453,184 - $505,867
4,499 Added 251.76%
6,286 $653,000
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $195,712 - $216,155
1,787 New
1,787 $203,000
Q1 2023

Apr 27, 2023

BUY
$96.86 - $114.01 $196,238 - $230,984
2,026 New
2,026 $205,000
Q3 2022

Nov 02, 2022

BUY
$96.76 - $112.03 $24,383 - $28,231
252 Added 13.06%
2,181 $211,000
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $196,893 - $237,980
1,929 New
1,929 $210,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Auxano Advisors, LLC Portfolio

Follow Auxano Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxano Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Auxano Advisors, LLC with notifications on news.